Skip to main content

Articles

Page 25 of 108

  1. Chemotherapy resistance resulting in incomplete pathologic response is associated with high risk of metastasis and early relapse in breast cancer. The aim of this study was to identify and evaluate biomarkers ...

    Authors: Andrea Aloia, Evgeniya Petrova, Stefan Tomiuk, Ute Bissels, Olivier Déas, Massimo Saini, Franziska Maria Zickgraf, Steve Wagner, Saskia Spaich, Marc Sütterlin, Andreas Schneeweiss, Manuel Reitberger, Silvia Rüberg, Bernhard Gerstmayer, David Agorku, Sebastian Knöbel…
    Citation: Breast Cancer Research 2015 17:146
  2. For efficient metastatic dissemination, tumor cells form invadopodia to degrade and move through three-dimensional extracellular matrix. However, little is known about the conditions that favor invadopodia for...

    Authors: Sarah J. Creed, Caroline P. Le, Mona Hassan, Cindy K. Pon, Sabine Albold, Keefe T. Chan, Matthew E. Berginski, Zhendong Huang, James E. Bear, J. Robert Lane, Michelle L. Halls, Davide Ferrari, Cameron J. Nowell and Erica K. Sloan
    Citation: Breast Cancer Research 2015 17:145
  3. Authors: Shandong Wu, Susan P. Weinstein, Michael J. DeLeo, Emily F. Conant, Jinbo Chen, Susan M. Domchek and Despina Kontos
    Citation: Breast Cancer Research 2015 17:144

    The original article was published in Breast Cancer Research 2015 17:67

  4. When measured using the computer-assisted method CUMULUS, mammographic density adjusted for age and body mass index predicts breast cancer risk. We asked if new mammographic density measures defined by higher ...

    Authors: Tuong Linh Nguyen, Ye Kyaw Aung, Christopher Francis Evans, Choi Yoon-Ho, Mark Anthony Jenkins, Joohon Sung, John Llewelyn Hopper and Yun-Mi Song
    Citation: Breast Cancer Research 2015 17:142
  5. Despite advances in early detection and adjuvant targeted therapies, breast cancer is still the second most common cause of cancer mortality among women. Tumor recurrence is one of the major contributors to br...

    Authors: Xue B. Holdman, Thomas Welte, Kimal Rajapakshe, Adam Pond, Cristian Coarfa, Qianxing Mo, Shixia Huang, Susan G. Hilsenbeck, Dean P. Edwards, Xiang Zhang and Jeffrey M. Rosen
    Citation: Breast Cancer Research 2015 17:141
  6. This study aimed at evaluating the overall survival (OS) gain associated with human epidermal growth factor receptor 2 (HER2)-directed therapies in patients with metastatic breast cancer (mBC).

    Authors: Diogo Mendes, Carlos Alves, Noémia Afonso, Fátima Cardoso, José Luís Passos-Coelho, Luís Costa, Sofia Andrade and Francisco Batel-Marques
    Citation: Breast Cancer Research 2015 17:140
  7. Authors: Miaad Al-Attar, Lubna Bashir, Lisa Grosvenor, Diane Lister, Elizabeth Denton, Moin Hoosein, Lakshmi Sundaram, Gayle McDonald and Niki Hartley
    Citation: Breast Cancer Research 2015 17(Suppl 1):P42

    This article is part of a Supplement: Volume 17 Supplement 1

  8. Authors: Alice Leaver, Simon Lowes, Peter Newton, Linsley Lunt, Anuradha Anand, Linda Hutchinson, Sally Athey, Amanda Jane Potterton, Sheetal Sharma and Alan Redman
    Citation: Breast Cancer Research 2015 17(Suppl 1):P4

    This article is part of a Supplement: Volume 17 Supplement 1

Annual Journal Metrics

  • 2022 Citation Impact
    7.4 - 2-year Impact Factor
    7.4 - 5-year Impact Factor
    1.764 - SNIP (Source Normalized Impact per Paper)
    2.408 - SJR (SCImago Journal Rank)

    2023 Speed
    20 days submission to first editorial decision for all manuscripts (Median)
    129 days submission to accept (Median)

    2023 Usage 
    2,432,781 downloads
    1,561 Altmetric mentions